{Reference Type}: Multicenter Study
{Title}: CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.
{Author}: Kriegsmann K;Ton GNHQ;Awwad MHS;Benner A;Bertsch U;Besemer B;Hänel M;Fenk R;Munder M;Dürig J;Blau IW;Huhn S;Hose D;Jauch A;Mann C;Weinhold N;Scheid C;Schroers R;von Metzler I;Schieferdecker A;Thomalla J;Reimer P;Mahlberg R;Graeven U;Kremers S;Martens UM;Kunz C;Hensel M;Seidel-Glätzer A;Weisel KC;Salwender HJ;Müller-Tidow C;Raab MS;Goldschmidt H;Mai EK;Hundemer M;
{Journal}: Leukemia
{Volume}: 38
{Issue}: 7
{Year}: 2024 Jul 3
{Factor}: 12.883
{DOI}: 10.1038/s41375-024-02290-y